175 related articles for article (PubMed ID: 2340517)
21. Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cells.
Gandhi V; Mineishi S; Huang P; Chapman AJ; Yang Y; Chen F; Nowak B; Chubb S; Hertel LW; Plunkett W
Cancer Res; 1995 Apr; 55(7):1517-24. PubMed ID: 7533664
[TBL] [Abstract][Full Text] [Related]
22. Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.
Xu YZ; Plunkett W
Biochem Pharmacol; 1992 Nov; 44(9):1819-27. PubMed ID: 1449536
[TBL] [Abstract][Full Text] [Related]
23. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
[TBL] [Abstract][Full Text] [Related]
24. Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.
Richardson KA; Vega TP; Richardson FC; Moore CL; Rohloff JC; Tomkinson B; Bendele RA; Kuchta RD
Biochem Pharmacol; 2004 Dec; 68(12):2337-46. PubMed ID: 15548380
[TBL] [Abstract][Full Text] [Related]
25. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
Roberts D; Peck C
Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
[TBL] [Abstract][Full Text] [Related]
26. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
White JC; Hines LH
Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
[TBL] [Abstract][Full Text] [Related]
27. Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints.
Leanza L; Miazzi C; Ferraro P; Reichard P; Bianchi V
Exp Cell Res; 2010 Dec; 316(20):3443-53. PubMed ID: 20603113
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
Hess G; Arnold W; Meyer zum Büschenfelde KH
Antimicrob Agents Chemother; 1981 Jan; 19(1):44-50. PubMed ID: 6166246
[TBL] [Abstract][Full Text] [Related]
29. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
Lech-Maranda E; Korycka A; Robak T
Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme.
Van Rompay AR; Johansson M; Karlsson A
Mol Pharmacol; 1999 Sep; 56(3):562-9. PubMed ID: 10462544
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.
Someya H; Shaddix SC; Tiwari KN; Secrist JA; Parker WB
J Pharmacol Exp Ther; 2003 Mar; 304(3):1314-22. PubMed ID: 12604712
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
Vrana JA; Kramer LB; Saunders AM; Zhang XF; Dent P; Povirk LF; Grant S
Biochem Pharmacol; 1999 Jul; 58(1):121-31. PubMed ID: 10403525
[TBL] [Abstract][Full Text] [Related]
34. In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU).
Tiefenthaler M; Hohla F; Irschick E; Strasser-Wozak E; Bacher N; Mühlmann O; Wein W; Konwalinka G
Immunobiology; 2003; 207(2):149-57. PubMed ID: 12675273
[TBL] [Abstract][Full Text] [Related]
35. Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines.
van Moorsel CJ; Pinedo HM; Veerman G; Guechev A; Smid K; Loves WJ; Vermorken JB; Postmus PE; Peters GJ
Biochem Pharmacol; 1999 Feb; 57(4):407-15. PubMed ID: 9933029
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
[TBL] [Abstract][Full Text] [Related]
37. Algorithmic modeling quantifies the complementary contribution of metabolic inhibitions to gemcitabine efficacy.
Kahramanoğullari O; Fantaccini G; Lecca P; Morpurgo D; Priami C
PLoS One; 2012; 7(12):e50176. PubMed ID: 23239976
[TBL] [Abstract][Full Text] [Related]
38. Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours.
Ruiz van Haperen VW; Veerman G; Boven E; Noordhuis P; Vermorken JB; Peters GJ
Biochem Pharmacol; 1994 Oct; 48(7):1327-39. PubMed ID: 7945430
[TBL] [Abstract][Full Text] [Related]
39. Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine.
Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
Biochem Pharmacol; 1984 Apr; 33(7):1059-63. PubMed ID: 6712715
[TBL] [Abstract][Full Text] [Related]
40. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
Liliemark JO; Plunkett W
Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
